Transcatheter Interventions for Tricuspid Regurgitation | JACC Journal Club

In this session of JACC Journal Club, we explore cutting-edge research on tricuspid transcatheter interventions, focusing on the TRISCEND II and TRILUMINATE trials. JACC Education Editor Vivek Kulkarni, MD, MHS, EdM, FACC and his co-lead, Megan Burke, MD, along with Suzanne Arnold, MD, JACC: Case Reports Editor-in-Chief Gilbert H. L. Tang, MD, MSc, MBA, FACC, Paul Fiorilli, MD, FACC, and Sajjad Sabir, MD discuss patient selection, procedural techniques, and key clinical findings, including the impact of quality of life improvements and the evolving role of tricuspid valve therapies. We also address methodological controversies, right heart function assessment, and the challenges of treating atrial functional TR. Additionally, we examine the long-term implications of transcatheter interventions and the potential for future clinical advancements in tricuspid regurgitation treatment. Join us as we unpack the latest evidence, clinical insights, and future directions in this rapidly advancing field!